CD5-dependent CK2 activation pathway regulates threshold for T Cell anergy

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 2918-2930

  Sestero, Christine M ^a   McGuire, Donald J ^b   De Sarno, Patrizia ^c   Brantley, Emily C ^d   Soldevila, Gloria ^e   Axtell, Robert C ^f   Raman, Chander ^a,b  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CD5 ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; THYMOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD5; CASEIN KINASE II; CELL DIFFERENTIATION; CLONAL ANERGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; FEMALE; GENE KNOCK-IN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84866153985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200065     Document Type: Article

References (45)

1. Tarakhovsky, A., S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Müller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269: 535-537.
2. Bikah, G., J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274: 1906-1909. (Pubitemid 26424770)
3. Perez-Villar, J. J., G. S. Whitney, M. A. Bowen, D. H. Hewgill, A. A. Aruffo, and S. B. Kanner. 1999. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 19: 2903-2912. (Pubitemid 29144535)
4. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300. (Pubitemid 34293426)
5. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650. (Pubitemid 351636247)
6. Rodamilans, B., I. G. Muñoz, E. Bragado-Nilsson, M. R. Sarrias, O. Padilla, F. J. Blanco, F. Lozano, and G. Montoya. 2007. Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain. J. Biol. Chem. 282: 12669-12677. (Pubitemid 47100586)
7. Resnick, D., A. Pearson, and M. Krieger. 1994. The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem. Sci. 19: 5-8. (Pubitemid 24028723)
8. Garza-Garcia, A., D. Esposito, W. Rieping, R. Harris, C. Briggs, M. H. Brown, and P. C. Driscoll. 2008. Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5. J. Mol. Biol. 378: 129-144.
9. Soldevila, G., C. Raman, and F. Lozano. 2011. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. Curr. Opin. Immunol. 23: 310-318.
10. Brown, M. H., and E. Lacey. 2010. A ligand for CD5 is CD5. J. Immunol. 185: 6068-6074.
11. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311. (Pubitemid 29028502)
12. Kassiotis, G., R. Zamoyska, and B. Stockinger. 2003. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197: 1007-1016. (Pubitemid 36523198)
13. Berland, R., S. Fiering, and H. H. Wortis. 2010. A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells. J. Immunol. 185: 7537-7543.
14. Azzam, H. S., J. B. DeJarnette, K. Huang, R. Emmons, C. S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love. 2001. Fine tuning of TCR signaling by CD5. J. Immunol. 166: 5464-5472. (Pubitemid 32374167)
15. Smith, K., B. Seddon, M. A. Purbhoo, R. Zamoyska, A. G. Fisher, and M. Merkenschlager. 2001. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194: 1253-1261. (Pubitemid 33055044)
16. Ling, K. W., J. P. van Hamburg, M. J. de Bruijn, D. Kurek, G. M. Dingjan, and R. W. Hendriks. 2007. GATA3 controls the expression of CD5 and the T cell receptor during CD4 T cell lineage development. Eur. J. Immunol. 37: 1043-1052. (Pubitemid 46925340)
17. Gary-Gouy, H., J. Harriague, A. Dalloul, E. Donnadieu, and G. Bismuth. 2002. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 168: 232-239. (Pubitemid 34014123)
18. Stamou, P., J. de Jersey, D. Carmignac, C. Mamalaki, D. Kioussis, and B. Stockinger. 2003. Chronic exposure to low levels of antigen in the periphery causes reversible functional impairment correlating with changes in CD5 levels in monoclonal CD8 T cells. J. Immunol. 171: 1278-1284. (Pubitemid 36900058)
19. Ryan, K. R., D. McCue, and S. M. Anderton. 2005. Fas-mediated death and sensory adaptation limit the pathogenic potential of autoreactive T cells after strong antigenic stimulation. J. Leukoc. Biol. 78: 43-50. (Pubitemid 40979942)
20. Tabbekh, M., K. Franciszkiewicz, H. Haouas, Y. Lécluse, K. Benihoud, C. Raman, and F. Mami-Chouaib. 2011. Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice. J. Immunol. 187: 102-109.
21. Calvo, J., J. M. Vildà, L. Places, M. Simarro, O. Padilla, D. Andreu, K. S. Campbell, C. Aussel, and F. Lozano. 1998. Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J. Immunol. 161: 6022-6029. (Pubitemid 28535971)
22. Raman, C., A. Kuo, J. Deshane, D. W. Litchfield, and R. P. Kimberly. 1998. Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. J. Biol. Chem. 273: 19183-19189. (Pubitemid 28366316)
23. Raman, C., and R. P. Kimberly. 1998. Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation. J. Immunol. 161: 5817-5820. (Pubitemid 28535945)
24. Montenarh, M. 2010. Cellular regulators of protein kinase CK2. Cell Tissue Res. 342: 139-146.
25. Filhol, O., and C. Cochet. 2009. Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair. Cell. Mol. Life Sci. 66: 1830-1839.
26. St-Denis, N. A., and D. W. Litchfield. 2009. Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 66: 1817-1829.
27. Axtell, R. C., L. Xu, S. R. Barnum, and C. Raman. 2006. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J. Immunol. 177: 8542-8549. (Pubitemid 44893816)
28. Axtell, R. C., M. S. Webb, S. R. Barnum, and C. Raman. 2004. Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J. Immunol. 173: 2928-2932. (Pubitemid 39141996)
29. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081. (Pubitemid 36570063)
30. Lee, E. C., D. Yu, J. Martinez de Velasco, L. Tessarollo, D. A. Swing, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56-65. (Pubitemid 32382387)
31. Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16: 406-412.
32. Tarakhovsky, A., W. Müller, and K. Rajewsky. 1994. Lymphocyte populations and immune responses in CD5-deficient mice. Eur. J. Immunol. 24: 1678-1684. (Pubitemid 24203778)
33. Kersh, G. J., and S. M. Hedrick. 1995. Role of TCR specificity in CD4 versus CD8 lineage commitment. J. Immunol. 154: 1057-1068.
34. + cells in the absence of CD5 signaling. Eur. J. Immunol. 39: 2233-2247.
35. +Treg cells. Immunol. Lett. 119: 103-113.
36. Brossard, C., M. Semichon, A. Trautmann, and G. Bismuth. 2003. CD5 inhibits signaling at the immunological synapse without impairing its formation. J. Immunol. 170: 4623-4629. (Pubitemid 36519968)
37. Zheng, Y., H. Qin, S. J. Frank, L. Deng, D. W. Litchfield, A. Tefferi, A. Pardanani, F. T. Lin, J. Li, B. Sha, and E. N. Benveniste. 2011. A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood 118: 156-166.
38. deWit, J., Y. Souwer, A. J. van Beelen, R. de Groot, F. J. Muller, H. Klaasse Bos, T. Jorritsma, M. L. Kapsenberg, E. C. de Jong, and S. M. van Ham. 2011. CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation. Blood 118: 6107-6114.
39. Jäger, A., and V. K. Kuchroo. 2010. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 72: 173-184.
40. Berland, R., and H. H. Wortis. 1998. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J. Immunol. 161: 277-285. (Pubitemid 28285533)
41. Yang, Y., C. H. Contag, D. Felsher, C. M. Shachaf, Y. Cao, L. A. Herzenberg, L. A. Herzenberg, and J. W. Tung. 2004. The E47 transcription factor negatively regulates CD5 expression during thymocyte development. Proc. Natl. Acad. Sci. USA 101: 3898-3902. (Pubitemid 38381074)
42. Chen, Z., A. Laurence, and J. J. O'Shea. 2007. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19: 400-408.
43. Paul, W. E. 2010. What determines Th2 differentiation, in vitro and in vivo? Immunol. Cell Biol. 88: 236-239.
44. Villarino, A. V., E. Gallo, and A. K. Abbas. 2010. STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms. J. Immunol. 185: 6461-6471.
45. Liu, L., S. Okada, X. F. Kong, A. Y. Kreins, S. Cypowyj, A. Abhyankar, J. Toubiana, Y. Itan, M. Audry, P. Nitschke, et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208: 1635-1648.